We are live on ! Find out more
NMTR

9 Meters Biopharma
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

42 hedge funds and large institutions have $3M invested in 9 Meters Biopharma in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,700% more call options, than puts

Call options by funds: $1.73M | Put options by funds: $36K

8% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 13

43% less funds holding

Funds holding: 74 → 42 (-32)

71% less capital invested

Capital invested by funds: $10.4M → $3M (-$7.4M)

79% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 38

Holders
42
Holders Change
-32
Holders Change %
-43.24%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
14
Reduced
13
Closed
38
Calls
$1.73M
Puts
$36K
Net Calls
+$1.69M
Net Calls Change
+$1.39M

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$95.4K
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$57K
3
MFG
Merit Financial Group
Georgia
+$54.2K
4
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$42K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$37.7K

Top Sellers

Rank Fund Capital Flow
1
E
Ergoteles
New York
-$196K
2
RCM
Requisite Capital Management
Texas
-$65K
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$51K
4
VF
Virtu Financial
New York
-$49K
5
VFA
Valeo Financial Advisors
Indiana
-$45K
Name Holding Trade Value Shares
Change 		Change in
Stake
Rockefeller Capital Management
26
Rockefeller Capital Management
New York
$1K – – –
Wells Fargo
27
Wells Fargo
California
$426 -$1.25K -548 -62%
PA
28
PSI Advisors
Florida
$378 – – –
MA
29
MCF Advisors
Kentucky
$346 – – –
HFM
30
Hartford Financial Management
Connecticut
$252 +$456 +200 New
BCMLT
31
Beacon Capital Management LLC (Tennessee)
Tennessee
$195 +$5 +2 +1%
PNC Financial Services Group
32
PNC Financial Services Group
Pennsylvania
$189 – – –
CA
33
CoreCap Advisors
Michigan
$127 +$230 +101 New
RFA
34
Register Financial Advisors
Georgia
$126 +$228 +100 New
TWA
35
TCI Wealth Advisors
Arizona
$63 +$114 +50 New
CPG
36
Cornerstone Planning Group
New Jersey
$52 +$57 +25 New
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$21 +$37.7K +16,519 New
Northwestern Mutual Wealth Management
38
Northwestern Mutual Wealth Management
Wisconsin
$3 +$2 +1 +100%
RCM
39
Raleigh Capital Management
North Carolina
$2 +$2 +1 +100%
E
40
Ergoteles
New York
– -$196K -45,573 Closed
RCM
41
Requisite Capital Management
Texas
– -$65K -15,000 Closed
Qube Research & Technologies (QRT)
42
Qube Research & Technologies (QRT)
United Kingdom
– -$51K -11,767 Closed
VF
43
Virtu Financial
New York
– -$49K -11,430 Closed
VFA
44
Valeo Financial Advisors
Indiana
– -$45K -10,484 Closed
Stifel Financial
45
Stifel Financial
Missouri
– -$32K -7,500 Closed
Bank of New York Mellon
46
Bank of New York Mellon
New York
– -$29K -6,655 Closed
Charles Schwab
47
Charles Schwab
California
– -$24K -5,388 Closed
RJA
48
Raymond James & Associates
Florida
– -$21K -4,905 Closed
Bank of Montreal
49
Bank of Montreal
Ontario, Canada
– -$19 -4,156 Closed
Goldman Sachs
50
Goldman Sachs
New York
– -$16K -3,817 Closed
1
2
3 4

NMTR Hedge Fund Activity: Q4 2022 in Review

42 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q4 2022, worth a combined $3M — down 71% from $10.4M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of NMTR and 8 opened new positions — a net loss of 30 holders — while 13 trimmed existing stakes and 14 added.

The largest buyer was HRT Financial, adding an estimated $95.4K. The largest seller was Ergoteles, exiting entirely with an estimated $196K sold.

  • 42 institutional investors held 9 Meters Biopharma (NMTR) as of Q4 2022, down from 74 in Q3 2022.
  • Funds reported $3M of 9 Meters Biopharma stock for Q4 2022, down 71% quarter-over-quarter.
  • 8 funds opened new 9 Meters Biopharma positions in Q4 2022 and 38 closed out, a net change of -30 holders.
  • The largest 9 Meters Biopharma buyer in Q4 2022 was HRT Financial, an estimated $95.4K added.
  • The largest 9 Meters Biopharma seller in Q4 2022 was Ergoteles, an estimated $196K sold.

Based on aggregated 13F filings for Q4 2022.